Detecció no invasiva de la participació del sistema immunitari en la resposta a la teràpia en glioblastoma en un model preclínic de ratolí immunocompetent

Researchers from the Biomedical Applications Group from the RMN (GABRMN) at the Universitat Autònoma de Barcelona have used non-invasive medical imaging approaches based in magnetic resonance, followed by machine learning analysis, in order to obtain therapy response biomarkers for glioblastoma preclinical murine models. Moreover, in this study, more than a half of the studied animals were cured by the therapeutic protocol used, with development of anti-tumour immune memory. This strategy could have translational potential for patients.